SeaStar Medical Holding Corp

SeaStar Medical Holding Corporation, formerly LMF Acquisition Opportunities, Inc. (Nasdaq: LMAO), completed its de-SPAC business combination with SeaStar Medical in October 2022, with the 8-K filed on October 19 of that year marking a key closing event. The SPAC was sponsored by LMF Acquisition Opportunities Sponsor, LLC and conducted its initial public offering in 2021, targeting the healthcare and medical device sector. SeaStar Medical focuses on selective cytopheretic device technology aimed at treating acute kidney injury and systemic inflammation. The combined company now operates as a publicly traded medical device firm. Visit SpacDesk and sign up for full transaction data, filings history, and sponsor analytics on this and hundreds of other SPAC deals.